We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Outperforms Symptom Analysis in Detecting Ovarian Cancer

By MedImaging International staff writers
Posted on 27 Aug 2009
In a recent study, physicians compared symptom analysis to ultrasound in predicting ovarian cancer.

The researchers from the University of Kentucky Chandler Medical Center-Markey Cancer Center (Lexington, KY, USA) selected 272 women participating in yearly transvaginal screening (TVS) from 31,748 women enrolled in a free screening project at the university, comparing symptom results to ultrasound and surgical pathology findings. They found TVS performed better than symptoms analysis for detecting malignancies (73.3% versus 20% sensitivity).

Whereas symptoms analysis performed better for distinguishing benign tumors (91.3% versus 74.4% specificity), adding symptom analysis to TVS actually resulted in poorer identification of malignancy (sensitivity = 16.7%), even as it improved the ability to distinguish benign tumors (specificity = 97.9%).

The investigators reported that the data indicate that while symptoms do identify ovarian malignancies, they are not as accurate as TVS. They added that informative symptoms could be expected to be absent in 80% of ovarian malignancies.

The study was published in the August 15, 2009, issue of the journal Cancer.

Related Links:

University of Kentucky Chandler Medical Center-Markey Cancer Center



Adjustable Mobile Barrier
M-458
Mammography System (Analog)
MAM VENUS
Half Apron
Demi
Diagnostic Ultrasound System
DC-80A

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.